Most pet owners probably do not associate the scientific name “thelaziosis” to eyeworm infestations experienced by their dogs. Click here to learn more.
At Boehringer Ingelheim, we prioritise the establishment and maintenance of public trust. Transparency is therefore a key pillar of our corporate culture.
A global initiative to reduce mortality, cardiovascular and kidney complications in type 2 diabetes through adherence to clinical guidelines. Learn more.
In season 2, we hear from a range of experts to explore further how the interconnected systems call for collaboration and approach to care. Learn more.
Patient documentary - From diagnosis to everyday living
Hear these four brave people share personal experiences of the impact being diagnosed with type 2 diabetes and heart disease has had on them, and more.
About 425 million adult people in the world are living with diabetes, with Type 2 diabetes accounting for 90 – 95 percent of all cases. Learn more here.
MORE GREEN: Environmental sustainability at a glance
On Earth Day, we share the progress of our global environmental sustainability MORE GREEN program and what the team is tackling, all 365 days of the year.
At Boehringer Ingelheim we attach great importance to sustainable planting on our company site – and to protecting the bees. Click here to find out more.
My.Making More Health, our platform for disadvantaged communities goes live, providing materials on health prevention for all. Click here to learn more.
COVID-19 USA StayHomeandFoster through GreaterGood.org | Boehringer Ingelheim
Our U.S. Animal Health Pet Vet group is sponsoring the #StayHomeandFoster initiative. Click here to find out more information and learn more about this.
Boehringer Ingelheim’s core principles and vision guide our work with patient organisations. Learn about how we collaborate with patient organisations.